These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12776774)

  • 1. A procedure for the detection of Stealth adulterant in urine samples.
    Valtier S; Cody JT
    Clin Lab Sci; 2002; 15(2):111-5. PubMed ID: 12776774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Stealth adulterant on immunoassay testing for drugs of abuse.
    Cody JT; Valtier S
    J Anal Toxicol; 2001 Sep; 25(6):466-70. PubMed ID: 11550822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing.
    Dasgupta A; Wahed A; Wells A
    Am J Clin Pathol; 2002 Feb; 117(2):325-9. PubMed ID: 11863230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing.
    Welsh KJ; Dierksen JE; Actor JK; Dasgupta A
    Am J Clin Pathol; 2013 Oct; 140(4):572-8. PubMed ID: 24045556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of endogenous urinary biomarkers for indirect detection of urine adulteration attempts by five different chemical adulterants in mass spectrometry methods.
    Steuer AE; Kamber D; Kraemer T
    Drug Test Anal; 2019 May; 11(5):638-648. PubMed ID: 30408836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens.
    Dasgupta A; Chughtai O; Hannah C; Davis B; Wells A
    Clin Chim Acta; 2004 Oct; 348(1-2):19-25. PubMed ID: 15369731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary ion electrophoresis of endogenous anions and anionic adulterants in human urine.
    Ferslew KE; Hagardorn AN; Robert TA
    J Forensic Sci; 2001 May; 46(3):615-26. PubMed ID: 11372999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
    Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
    Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the use of urine, hair, sweat and saliva to detect drug use.
    Dolan K; Rouen D; Kimber J
    Drug Alcohol Rev; 2004 Jun; 23(2):213-7. PubMed ID: 15370028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.
    Schänzer W; Geyer H; Fusshöller G; Halatcheva N; Kohler M; Parr MK; Guddat S; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2006; 20(15):2252-8. PubMed ID: 16804957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.
    Ewald AH; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):170-4. PubMed ID: 17632045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.